Precision Medicine Tools to Guide Therapy and Monitor Response to Treatment in a HER-2+ Gastric Cancer Patient: Case Report

Trastuzumab, has played a major role in improving treatment outcomes in HER-2 positive gastric cancer. However, once there is disease progression there is a paucity of evidence for second line therapy. Patient-derived xenografts (PDXs) in combination with liquid biopsies can help guide individual th...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguilar-Mahecha, Adriana, Joseph, Sarah, Cavallone, Luca, Buchanan, Marguerite, Krzemien, Urszula, Batist, Gerald, Basik, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691136/
https://www.ncbi.nlm.nih.gov/pubmed/31448226
http://dx.doi.org/10.3389/fonc.2019.00698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691136/
https://www.ncbi.nlm.nih.gov/pubmed/31448226
http://dx.doi.org/10.3389/fonc.2019.00698

Ejemplares similares